Medical Devices Startups

Abbott Global Point of Care provides portable diagnostic analyzers and testing systems used at the point of care by healthcare professionals, enabling on-site blood chemistry, lipid, and other tests with results that can upload directly to electronic medical records. Its products serve clinical and near-patient testing settings in the in-vitro diagnostics category.

1 investor

Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure. The company runs Phase I and Phase II clinical programs and is publicly traded (TSXV: HEM | OTCQB: HMTXF).

1 investor

HemostOD engineers and manufactures universal (HLA-low) platelets using a proprietary platform that immortalizes hematopoietic progenitor cells and generates platelets via microfluidic bioreactors. The preclinical biotech targets applications in thrombocytopenia, tissue-targeted cargo delivery, regenerative medicine, and therapeutic stem cell culture.

1 investor

hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medical and biomanufacturing applications. The platform removes disease triggers and harmful agents from the bloodstream or processes biological materials with high selectivity and scalability.

1 investor

Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.

1 investor

HEPTA Medical develops a microwave ablation platform with an integrated tissue temperature sensor and predictive software for real-time monitoring during ablation procedures. The technology is designed for medical practitioners performing ablation treatments.

1 investor

Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction. Its compounds target multiple pathways through the upregulation of certain non-coding RNAs to promote heart regeneration.

1 investor

Hera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.

1 investor

Hera Women's Health partners with independent women's health providers to deliver clinical and operational support, modernizing practice operations while preserving physician independence and community relationships. The organization aims to improve healthcare delivery for women by removing administrative barriers and enabling providers to focus on patient care.

1 investor

Heran Partners is a venture capital firm investing in healthcare and life sciences companies that use enabling technologies—hardware, software, or services—to address unmet clinical needs and improve patient outcomes. The firm focuses on companies at seed through Series B stages that combine financial returns with societal impact by advancing treatments, generating actionable patient insights, or improving drug development efficiency.

1 investor

Hermes Biosciences develops a benchtop system for isolating extracellular vesicles and exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

1 investor

HeroSupport develops adaptive imaging and treatment tables for cancer radiotherapy that automatically adjust to individual patients, enhancing treatment precision and reducing discomfort for radiation oncology centers.

1 investor

HerScan provides community-based breast ultrasound screenings for women, delivered through mobile health events across the U.S. as a supplemental tool to mammography, with scans interpreted by board-certified radiologists. It targets women, particularly those with dense breast tissue, offering appointments without a referral for a single upfront cost.

1 investor

Hesperos develops "Human-on-a-Chip" organ-on-a-chip platforms, offering custom multi-organ models (up to 5 organ or tissue types) with functional readouts such as gene expression and electrophysiology. The systems provide pre-clinical efficacy and toxicity data on drugs and chemicals for the pharmaceutical, cosmetic, and food industries.

1 investor

A medical device manufacturer specializing in production equipment and components for catheter systems, including balloon catheters, interventional catheters, and guidewires for medical applications.

1 investor

High Q Technologies builds quantum-enabled scientific instruments that apply microwave quantum optics techniques to electron paramagnetic resonance (EPR) spectroscopy for ultra-high sensitivity biophysical and chemical analysis. Its technology targets protein structure determination and drug discovery, serving researchers and pharmaceutical development.

1 investor

High5Health partners with oral surgeons and endodontists to deliver specialty dental care services. The company operates specialty dental practices through collaborative partnerships with dental professionals.

1 investor

HighCape Partners is a venture capital firm investing in connected health, medical devices, and biotechnology companies. The firm provides capital and operational expertise to early-stage and growth-stage life sciences companies.

1 investor

H.I.G. HealthBridge Capital Partners is a growth equity investment fund focused on healthcare companies across medical devices, biopharmaceuticals, digital health, diagnostics, and related services.

1 investor

Highfield Diagnostics develops point-of-care diagnostic sensors using laser-based technologies on paper substrates, targeting detection of diseases like tuberculosis and leishmaniasis in resource-limited settings. The company applies laser engineering and microfluidics expertise to create affordable, low-cost diagnostic tests.

1 investor

Higo builds medical infrastructure for remote, distributed healthcare, providing a device and platform that let doctors perform medical-grade examinations of patients at home rather than in clinics. It is developed with physicians from academic and medical institutions and targets families and healthcare systems.

1 investor

Hilco Vision manufactures and distributes lens care products including cleaners, wipes, and protective accessories for eyewear. The company serves optical practices and eyewear retailers with both standard and custom-branded solutions.

1 investor

Hilditch Group specializes in the resale and remarketing of used medical equipment for hospitals and healthcare organizations across the UK and Europe. The company helps healthcare providers convert redundant or decommissioned medical devices into value while supporting sustainability and circular-economy principles.

1 investor

Hillrom, now part of Baxter, develops connected medical devices and clinical systems for hospitals, physician offices, pharmacies and home care, including smart beds, vital signs monitors, infusion pumps, nurse call and communication systems, diagnostic and examination tools, respiratory and surgical technologies, and pharmaceuticals. Its products integrate with electronic health records and unify onto a single platform to support patient safety, care coordination and clinical workflows.

1 investor